InvaGen Pharmaceuticals, Inc. recalls Testosterone Cypionate Injection, USP, 1000 mg/10 mL (100 mg/mL), For intramuscular use only, 10 mL Vial, Multiple-Dose…
- Recall date
- March 22, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1125-2019
- FDA classification
- Class II
- Brand / firm
- InvaGen Pharmaceuticals, Inc.
- Sold / distributed
- Nationwide in the U.S.A.
Why it was recalled
Presence of Particulate Matter.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Testosterone Cypionate Injection, USP, 1000 mg/10 mL (100 mg/mL), For intramuscular use only, 10 mL Vial, Multiple-Dose, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc., 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise, FL 33323, NDC 69097-536-37.
Get recall alerts
Free email alert whenever InvaGen Pharmaceuticals, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: InvaGen Pharmaceuticals, Inc.